Brokerages forecast that LHC Group, Inc. (NASDAQ:LHCG) will announce $0.81 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for LHC Group’s earnings, with estimates ranging from $0.76 to $0.87. LHC Group posted earnings per share of $0.63 in the same quarter last year, which would suggest a positive year over year growth rate of 28.6%. The company is scheduled to issue its next earnings report after the market closes on Wednesday, August 1st.
According to Zacks, analysts expect that LHC Group will report full year earnings of $3.50 per share for the current financial year, with EPS estimates ranging from $3.47 to $3.52. For the next fiscal year, analysts forecast that the business will post earnings of $4.13 per share, with EPS estimates ranging from $4.02 to $4.25. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research firms that cover LHC Group.
LHC Group (NASDAQ:LHCG) last released its earnings results on Wednesday, May 2nd. The health services provider reported $0.63 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.03. LHC Group had a net margin of 4.07% and a return on equity of 9.29%. The company had revenue of $291.10 million for the quarter, compared to analyst estimates of $295.21 million. During the same quarter last year, the firm earned $0.53 EPS. The firm’s quarterly revenue was up 19.2% compared to the same quarter last year.
Shares of LHC Group traded down $0.01, hitting $86.31, on Thursday, Marketbeat reports. 4,029 shares of the company’s stock traded hands, compared to its average volume of 277,656. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.65 and a current ratio of 1.65. LHC Group has a one year low of $56.76 and a one year high of $89.17. The firm has a market cap of $2.85 billion, a P/E ratio of 35.74, a P/E/G ratio of 1.37 and a beta of 0.61.
In other LHC Group news, insider Joshua L. Proffitt sold 10,556 shares of the firm’s stock in a transaction on Thursday, May 17th. The shares were sold at an average price of $75.20, for a total value of $793,811.20. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Donald Dwayne Stelly sold 3,307 shares of the firm’s stock in a transaction on Monday, June 11th. The stock was sold at an average price of $79.76, for a total transaction of $263,766.32. Following the completion of the sale, the chief operating officer now directly owns 109,145 shares in the company, valued at approximately $8,705,405.20. The disclosure for this sale can be found here. In the last three months, insiders sold 16,863 shares of company stock worth $1,274,628. Insiders own 6.80% of the company’s stock.
Institutional investors have recently made changes to their positions in the business. SG Americas Securities LLC bought a new stake in LHC Group in the 1st quarter worth $105,000. Envestnet Asset Management Inc. bought a new stake in LHC Group in the 1st quarter worth $134,000. Bank of Montreal Can grew its holdings in LHC Group by 251.9% in the 2nd quarter. Bank of Montreal Can now owns 2,481 shares of the health services provider’s stock worth $212,000 after acquiring an additional 1,776 shares during the last quarter. Cubist Systematic Strategies LLC grew its holdings in LHC Group by 36.9% in the 1st quarter. Cubist Systematic Strategies LLC now owns 2,636 shares of the health services provider’s stock worth $162,000 after acquiring an additional 711 shares during the last quarter. Finally, Jefferies Group LLC bought a new stake in LHC Group in the 4th quarter worth $200,000. 94.26% of the stock is currently owned by institutional investors and hedge funds.
LHC Group Company Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Read More: Understanding Stock Ratings
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.